市場調査レポート

商品コード

1479992

感染管理市場の評価：タイプ・製品・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Infection Control Market Assessment, By Type, By Product, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年05月17日
発行: Market Xcel - Markets and Data
ページ情報: 英文 234 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 653,760円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 828,096円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,191,296円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.28円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の感染管理の市場規模は、2023年の1,062億1,000万米ドルから、2024年から2031年の予測期間中は6.16%のCAGRで推移し、2031年には1,713億4,000万米ドルの規模に成長すると予測されています。

同市場の成長を支えているのは、多剤耐性菌の脅威の高まり、ヘルスケア産業からの要求の高まり、臨床・外科手術の増加、急性呼吸器疾患の脅威を軽減するための各種規制機関による厳格なガイドラインの導入などです。

医療支出の増加は、世界の感染管理市場の主要動向のひとつです。 American Medical Associationの推計によると、米国の医療支出は2022年に4兆4,000億米ドル (1人当たり13,493米ドル) に増加しています。感染管理対策への要求が高まっているのは、ヘルスケア環境における厳格さが増していることにも起因しています。外科手術の必要性の拡大や、老齢人口の増加のため、ヘルスケア施設は厳格な洗浄方法を採用しています。このため、堅牢な感染管理製品およびサービスの需要が高まっています。

技術革新とAIもまた、今後数年間の市場の成長を支える上で重要な役割を果たすと予想されています。自動衛生ディスペンサー、紫外線消毒システム、ロボットクリーナーなどの技術革新が人気を集めています。進歩や製品革新は感染管理の合理化に役立ち、市場に有利な成長機会をもたらすと期待されています。

また、世界中のさまざまな地域で感染管理プログラムが導入されていることも、世界の感染管理市場の成長を後押しする主な要因です。例えば、インドのRajpuraにあるAryans Institute of Nursingは、MullanpurのHomi Bhabha Cancer Hospitalと共同で、2024年5月に感染管理と予防のデモンストレーションを実施しました。講演者は、感染管理と予防の重要性を振り返り、科学的アプローチが院内感染の予防をサポートし、微生物が医療従事者や患者、訪問者に広がる脅威をいかに軽減するかについて詳しく説明しました。

外科手術の必要性の拡大が市場需要を押し上げる：

さまざまな慢性疾患の有病率の増加は、外科的処置の必要性を促進し、世界中のさまざまな地域における感染管理製品およびサービスの必要性を増大させています。手術部位の感染は院内感染の20%を占め、世界全体での有病率は2.5～41.9%です。さまざまな健康状態を効果的に治療するための外科的介入に対する要求が高まっているため、医療機関は無菌環境を維持するための投資を増やしており、感染管理製品およびサービスが増加しています。外科手術の中でも低侵襲手術の増加により、高度な滅菌プロセスやサービスの必要性が高まっています。厳しい規制による衛生と清潔さの優先順位の高まりと、患者の健康増進の重視の高まりが、市場の需要をさらに増大させています。

AIと感染管理の統合が有利な成長機会をもたらす：

AIと感染管理の統合が成功すれば、医療機関は抱えている問題を認識し、AIが効果的なソリューションを提供できるかどうかを判断できるようになります。AIシステムは、マスクのコンプライアンス監査や環境清掃などの反復作業を軽減し、特定の患者グループのビッグデータ分析の機会を提供すると期待されています。過去数年の間に、AIは手作業によるスクラビングから、どこに重点を置くべきかを判断する能力を持つインテリジェントロボットへと洗浄を進化させてきました。AIの支援により、ロボットは空気や環境の質をリアルタイムで監視し、追加入力が必要な場所をターゲットにすることもできます。AIはまた、感染管理業務の合理化において専門家を支援し、世界の感染管理市場規模を強化します。

当レポートでは、世界の感染管理の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
タイプ別
- サービス
- 機器
- 消耗品
製品別
- 殺菌製品
- 洗浄・消毒用品
- 個人防護バリア
- 内視鏡再処理製品
- 抗菌表面
- その他
用途別
- 手術器具
- 内視鏡
- 超音波プローブ
- その他
エンドユーザー別
- 病院
- クリニック
- 診断ラボ
- 医療機器企業
- バイオテクノロジーおよび製薬企業
- その他
流通チャネル別
- 小売
- サードパーティ販売業者
- 直接入札
地域別
- 北米
- 欧州
- 南米
- アジア太平洋
- 中東・アフリカ
企業別市場シェア

第6章世界の感染管理市場の展望：地域別

北米
欧州
南米
アジア太平洋
中東・アフリカ

第6章市場マッピング

タイプ別
製品別
用途別
エンドユーザー別
流通チャネル別
地域別

第7章マクロ環境・産業構造

需給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長促進因子
成長阻害因子 (課題・制約)

第9章規制枠組みとイノベーション

特許情勢
規制当局の承認
イノベーション/新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析（参入5社）
特許分析（該当する場合）

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

M Company
Getinge AB
Steric Plc
Sotera Health
Advanced Sterilization Products, Inc.
MATACHANA GROUP
MMM Group
Belimed AG
Halyard Health (Owens & Minor, Inc.)
Ecolab Inc.

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 2.Global Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 3.Global Infection Control Market Share (%), By Type, 2017-2031F
Figure 4.Global Infection Control Market Share (%), By Product, 2017-2031F
Figure 5.Global Infection Control Market Share (%), By Application, 2017-2031F
Figure 6.Global Infection Control Market Share (%), By End-user, 2017-2031F
Figure 7.Global Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 8.Global Infection Control Market Share (%), By Region, 2017-2031F
Figure 9.North America Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 10.North America Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 11.North America Infection Control Market Share (%), By Type, 2017-2031F
Figure 12.North America Infection Control Market Share (%), By Product, 2017-2031F
Figure 13.North America Infection Control Market Share (%), By Application, 2017-2031F
Figure 14.North America Infection Control Market Share (%), By End-user, 2017-2031F
Figure 15.North America Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 16.North America Infection Control Market Share (%), By Country, 2017-2031F
Figure 17.United States Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 18.United States Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 19.United States Infection Control Market Share (%), By Type, 2017-2031F
Figure 20.United States Infection Control Market Share (%), By Product, 2017-2031F
Figure 21.United States Infection Control Market Share (%), By Application, 2017-2031F
Figure 22.United States Infection Control Market Share (%), By End-user, 2017-2031F
Figure 23.United States Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 24.Canada Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 25.Canada Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 26.Canada Infection Control Market Share (%), By Type, 2017-2031F
Figure 27.Canada Infection Control Market Share (%), By Product, 2017-2031F
Figure 28.Canada Infection Control Market Share (%), By Application, 2017-2031F
Figure 29.Canada Infection Control Market Share (%), By End-user, 2017-2031F
Figure 30.Canada Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 31.Mexico Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 32.Mexico Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 33.Mexico Infection Control Market Share (%), By Type, 2017-2031F
Figure 34.Mexico Infection Control Market Share (%), By Product, 2017-2031F
Figure 35.Mexico Infection Control Market Share (%), By Application, 2017-2031F
Figure 36.Mexico Infection Control Market Share (%), By End-user, 2017-2031F
Figure 37.Mexico Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 38.Europe Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 39.Europe Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 40.Europe Infection Control Market Share (%), By Type, 2017-2031F
Figure 41.Europe Infection Control Market Share (%), By Product, 2017-2031F
Figure 42.Europe Infection Control Market Share (%), By Application, 2017-2031F
Figure 43.Europe Infection Control Market Share (%), By End-user, 2017-2031F
Figure 44.Europe Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 45.Europe Infection Control Market Share (%), By Country, 2017-2031F
Figure 46.Germany Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 47.Germany Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 48.Germany Infection Control Market Share (%), By Type, 2017-2031F
Figure 49.Germany Infection Control Market Share (%), By Product, 2017-2031F
Figure 50.Germany Infection Control Market Share (%), By Application, 2017-2031F
Figure 51.Germany Infection Control Market Share (%), By End-user, 2017-2031F
Figure 52.Germany Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 53.France Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 54.France Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 55.France Infection Control Market Share (%), By Type, 2017-2031F
Figure 56.France Infection Control Market Share (%), By Product, 2017-2031F
Figure 57.France Infection Control Market Share (%), By Application, 2017-2031F
Figure 58.France Infection Control Market Share (%), By End-user, 2017-2031F
Figure 59.France Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 60.Italy Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 61.Italy Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 62.Italy Infection Control Market Share (%), By Type, 2017-2031F
Figure 63.Italy Infection Control Market Share (%), By Product, 2017-2031F
Figure 64.Italy Infection Control Market Share (%), By Application, 2017-2031F
Figure 65.Italy Infection Control Market Share (%), By End-user, 2017-2031F
Figure 66.Italy Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 67.United Kingdom Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 68.United Kingdom Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 69.United Kingdom Infection Control Market Share (%), By Type, 2017-2031F
Figure 70.United Kingdom Infection Control Market Share (%), By Product, 2017-2031F
Figure 71.United Kingdom Infection Control Market Share (%), By Application, 2017-2031F
Figure 72.United Kingdom Infection Control Market Share (%), By End-user, 2017-2031F
Figure 73.United Kingdom Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 74.Russia Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 75.Russia Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 76.Russia Infection Control Market Share (%), By Type, 2017-2031F
Figure 77.Russia Infection Control Market Share (%), By Product, 2017-2031F
Figure 78.Russia Infection Control Market Share (%), By Application, 2017-2031F
Figure 79.Russia Infection Control Market Share (%), By End-user, 2017-2031F
Figure 80.Russia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 81.Netherlands Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 82.Netherlands Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 83.Netherlands Infection Control Market Share (%), By Type, 2017-2031F
Figure 84.Netherlands Infection Control Market Share (%), By Product, 2017-2031F
Figure 85.Netherlands Infection Control Market Share (%), By Application, 2017-2031F
Figure 86.Netherlands Infection Control Market Share (%), By End-user, 2017-2031F
Figure 87.Netherlands Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 88.Spain Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 89.Spain Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 90.Spain Infection Control Market Share (%), By Type, 2017-2031F
Figure 91.Spain Infection Control Market Share (%), By Product, 2017-2031F
Figure 92.Spain Infection Control Market Share (%), By Application, 2017-2031F
Figure 93.Spain Infection Control Market Share (%), By End-user, 2017-2031F
Figure 94.Spain Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 95.Turkey Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 96.Turkey Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 97.Turkey Infection Control Market Share (%), By Type, 2017-2031F
Figure 98.Turkey Infection Control Market Share (%), By Product, 2017-2031F
Figure 99.Turkey Infection Control Market Share (%), By Application, 2017-2031F
Figure 100.Turkey Infection Control Market Share (%), By End-user, 2017-2031F
Figure 101.Turkey Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 102.Poland Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 103.Poland Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 104.Poland Infection Control Market Share (%), By Type, 2017-2031F
Figure 105.Poland Infection Control Market Share (%), By Product, 2017-2031F
Figure 106.Poland Infection Control Market Share (%), By Application, 2017-2031F
Figure 107.Poland Infection Control Market Share (%), By End-user, 2017-2031F
Figure 108.Poland Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 109.South America Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 110.South America Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 111.South America Infection Control Market Share (%), By Type, 2017-2031F
Figure 112.South America Infection Control Market Share (%), By Product, 2017-2031F
Figure 113.South America Infection Control Market Share (%), By Application, 2017-2031F
Figure 114.South America Infection Control Market Share (%), By End-user, 2017-2031F
Figure 115.South America Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 116.South America Infection Control Market Share (%), By Country, 2017-2031F
Figure 117.Brazil Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 118.Brazil Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 119.Brazil Infection Control Market Share (%), By Type, 2017-2031F
Figure 120.Brazil Infection Control Market Share (%), By Product, 2017-2031F
Figure 121.Brazil Infection Control Market Share (%), By Application, 2017-2031F
Figure 122.Brazil Infection Control Market Share (%), By End-user, 2017-2031F
Figure 123.Brazil Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 124.Argentina Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 125.Argentina Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 126.Argentina Infection Control Market Share (%), By Type, 2017-2031F
Figure 127.Argentina Infection Control Market Share (%), By Product, 2017-2031F
Figure 128.Argentina Infection Control Market Share (%), By Application, 2017-2031F
Figure 129.Argentina Infection Control Market Share (%), By End-user, 2017-2031F
Figure 130.Argentina Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 131.Asia-Pacific Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 132.Asia-Pacific Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 133.Asia-Pacific Infection Control Market Share (%), By Type, 2017-2031F
Figure 134.Asia-Pacific Infection Control Market Share (%), By Product, 2017-2031F
Figure 135.Asia-Pacific Infection Control Market Share (%), By Application, 2017-2031F
Figure 136.Asia-Pacific Infection Control Market Share (%), By End-user, 2017-2031F
Figure 137.Asia- Pacific Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 138.Asia-Pacific Infection Control Market Share (%), By Country, 2017-2031F
Figure 139.India Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 140.India Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 141.India Infection Control Market Share (%), By Type, 2017-2031F
Figure 142.India Infection Control Market Share (%), By Product, 2017-2031F
Figure 143.India Infection Control Market Share (%), By Application, 2017-2031F
Figure 144.India Infection Control Market Share (%), By End-user, 2017-2031F
Figure 145.India Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 146.China Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 147.China Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 148.China Infection Control Market Share (%), By Type, 2017-2031F
Figure 149.China Infection Control Market Share (%), By Product, 2017-2031F
Figure 150.China Infection Control Market Share (%), By Application, 2017-2031F
Figure 151.China Infection Control Market Share (%), By End-user, 2017-2031F
Figure 152.China Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 153.Japan Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 154.Japan Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 155.Japan Infection Control Market Share (%), By Type, 2017-2031F
Figure 156.Japan Infection Control Market Share (%), By Product, 2017-2031F
Figure 157.Japan Infection Control Market Share (%), By Application, 2017-2031F
Figure 158.Japan Infection Control Market Share (%), By End-user, 2017-2031F
Figure 159.Japan Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 160.Australia Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 161.Australia Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 162.Australia Infection Control Market Share (%), By Type, 2017-2031F
Figure 163.Australia Infection Control Market Share (%), By Product, 2017-2031F
Figure 164.Australia Infection Control Market Share (%), By Application, 2017-2031F
Figure 165.Australia Infection Control Market Share (%), By End-user, 2017-2031F
Figure 166.Australia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 167.Vietnam Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 168.Vietnam Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 169.Vietnam Infection Control Market Share (%), By Type, 2017-2031F
Figure 170.Vietnam Infection Control Market Share (%), By Product, 2017-2031F
Figure 171.Vietnam Infection Control Market Share (%), By Application, 2017-2031F
Figure 172.Vietnam Infection Control Market Share (%), By End-user, 2017-2031F
Figure 173.Vietnam Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 174.South Korea Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 175.South Korea Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 176.South Korea Infection Control Market Share (%), By Type, 2017-2031F
Figure 177.South Korea Infection Control Market Share (%), By Product, 2017-2031F
Figure 178.South Korea Infection Control Market Share (%), By Application, 2017-2031F
Figure 179.South Korea Infection Control Market Share (%), By End-user, 2017-2031F
Figure 180.South Korea Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 181.Indonesia Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 182.Indonesia Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 183.Indonesia Infection Control Market Share (%), By Type, 2017-2031F
Figure 184.Indonesia Infection Control Market Share (%), By Product, 2017-2031F
Figure 185.Indonesia Infection Control Market Share (%), By Application, 2017-2031F
Figure 186.Indonesia Infection Control Market Share (%), By End-user, 2017-2031F
Figure 187.Indonesia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 188.Philippines Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 189.Philippines Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 190.Philippines Infection Control Market Share (%), By Type, 2017-2031F
Figure 191.Philippines Infection Control Market Share (%), By Product, 2017-2031F
Figure 192.Philippines Infection Control Market Share (%), By Application, 2017-2031F
Figure 193.Philippines Infection Control Market Share (%), By End-user, 2017-2031F
Figure 194.Philippines Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 195.Middle East & Africa Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 196.Middle East & Africa Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 197.Middle East & Africa Infection Control Market Share (%), By Type, 2017-2031F
Figure 198.Middle East & Africa Infection Control Market Share (%), By Product, 2017-2031F
Figure 199.Middle East & Africa Infection Control Market Share (%), By Application, 2017-2031F
Figure 200.Middle East & Africa Infection Control Market Share (%), By End-user, 2017-2031F
Figure 201.Middle East & Africa Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 202.Middle East & Africa Infection Control Market Share (%), By Country, 2017-2031F
Figure 203.Saudi Arabia Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 204.Saudi Arabia Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 205.Saudi Arabia Infection Control Market Share (%), By Type, 2017-2031F
Figure 206.Saudi Arabia Infection Control Market Share (%), By Product, 2017-2031F
Figure 207.Saudi Arabia Infection Control Market Share (%), By Application, 2017-2031F
Figure 208.Saudi Arabia Infection Control Market Share (%), By End-user, 2017-2031F
Figure 209.Saudi Arabia Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 210.UAE Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 211.UAE Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 212.UAE Infection Control Market Share (%), By Type, 2017-2031F
Figure 213.UAE Infection Control Market Share (%), By Product, 2017-2031F
Figure 214.UAE Infection Control Market Share (%), By Application, 2017-2031F
Figure 215.UAE Infection Control Market Share (%), By End-user, 2017-2031F
Figure 216.UAE Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 217.South Africa Infection Control Market, By Value, In USD Billion, 2017-2031F
Figure 218.South Africa Infection Control Market, By Volume, In Million Units, 2017-2031F
Figure 219.South Africa Infection Control Market Share (%), By Type, 2017-2031F
Figure 220.South Africa Infection Control Market Share (%), By Product, 2017-2031F
Figure 221.South Africa Infection Control Market Share (%), By Application, 2017-2031F
Figure 222.South Africa Infection Control Market Share (%), By End-user, 2017-2031F
Figure 223.South Africa Infection Control Market Share (%), By Distribution Channel, 2017-2031F
Figure 224.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226.By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228.By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11337

Global infection control market is projected to witness a CAGR of 6.16% during the forecast period 2024-2031F, growing from USD 106.21 billion in 2023 to USD 171.34 billion in 2031F. The market's growth is supported by the escalating threat of multidrug-resistant organisms, rising requirements from the healthcare industry, increasing number of clinical and surgical procedures, and the introduction of stringent guidelines by various regulatory bodies to reduce the threat of acute respiratory diseases.

Increasing healthcare spending is one of the major global infection control market trends. According to the estimates of the American Medical Association, health spending in the United States increased to USD 13,493 per capita or USD 4.4 trillion in 2022. The growing requirement for infection control measures can also be attributed to the increasing stringency in healthcare settings. Due to the rising requirement for surgical interventions and the growing geriatric population, healthcare establishments are adopting stringent cleaning practices, as the weakened immunity of such patients makes them more susceptible to various infections. Thus, this is propelling the demand for robust infection control products and services.

Technological innovations and artificial intelligence are also expected to play a crucial role in supporting the market's growth in the coming years. Innovations such as automated hygiene dispensers, ultraviolet disinfection systems, and robotic cleaners are gaining traction. Advancements and product innovations are expected to aid in streamlining infection control, providing lucrative growth opportunities for the market.

The introduction of infection control programs in various regions across the globe is another major factor boosting global infection control market growth. For instance, the Aryans Institute of Nursing, Rajpura, India, organized a demonstration of infection control and prevention in May 2024 in collaboration with the Homi Bhabha Cancer Hospital, Mullanpur, India. The speakers reflected on the importance of infection control and prevention and elaborated on how the scientific approach supports the prevention of hospital-acquired infections and reduces the threat of microorganisms spreading to healthcare providers, patients, and visitors.

Growing Requirement for Surgical Procedures Boosts Market Demand

The increasing prevalence of different chronic diseases is propelling the requirement for surgical intervention, augmenting the requirement for infection control products and services in various regions across the globe. Surgical site infections account for 20% of hospital-acquired infections, with a pooled prevalence of 2.5-41.9% globally. Due to the heightened requirement for surgical interventions for effective treatment of various health conditions, infection control products and services are increasing as healthcare institutes are increasingly investing in maintaining sterile environments. The rise in the number of minimally invasive surgeries, among other surgical procedures, necessitates the requirement for advanced sterilization processes and services. The growing prioritization of hygiene and cleanliness due to stringent regulations and increasing emphasis on enhancing patient health further augment market demand.

Integration of AI with Infection Control Provides Lucrative Growth Opportunities

The successful integration of artificial intelligence (AI) with infection control will allow medical institutions to recognize the problems they have and determine if artificial intelligence is able to provide an effective solution. AI systems are expected to offload repetitive tasks such as mask compliance auditing and environmental cleaning and offer opportunities for big data analytics of a specific patient group. Over the past years, artificial intelligence has evolved cleaning from manual scrubbing to intelligent robots that have the ability to determine where to focus. With the assistance of artificial intelligence, robots are also able to monitor the air and environment quality in real time and target areas that require additional inputs. Artificial intelligence will also aid professionals in streamlining infection control operations, bolstering the global infection control market size.

North America Accounts for a Significant Share of the Market

The expansion of the market in the region is supported by the strong presence of various market players in North America, the presence of a well-established healthcare infrastructure, and the increasing adoption of infection control technologies due to growing awareness. The rising prevalence of healthcare-associated infections, expansion of the geriatric population, and increasing number of clinics and hospitals are other major factors propelling the demand for infection control in North America. According to the estimates of the Centers for Disease Control, 1.7 million infections and 99,000 associated deaths occur in American hospitals every year. The increased investments by the leading market players towards novel product development and strategic partnerships and collaborations to promote innovations are further boosting the market's growth in North America. The surge in the requirement for surgical procedures due to the rising prevalence of chronic diseases and disorders is another major factor augmenting the demand for infection control products and services.

Demand for Consumable Expected to Witness Significant Increase

The increased demand for consumables can be attributed to the short life cycle and consistent usage of these products. Personal protective equipment is used to provide a barrier between healthcare providers and microorganisms, reducing the risk of exposure. The selection of the products is made after a thorough risk assessment. They should be checked regularly to ensure that their integrity has not been compromised and should be evaluated for the expiration date as well. The segment's growth is boosted by successful collaborations and acquisitions. In May 2024, KARAM Safety acquired Midas Safety India to strengthen their position in personal protective equipment in India.

Additionally, the service segment is also expected to witness significant growth in the coming years. The expansion of the service segment can be attributed to increasing awareness about the availability and benefits of such services and a growing inclination towards reducing expenditures in sectors, including food and beverages, pharmaceutical, biotechnology, and healthcare.

Hospitals Hold Significant Share in the Global Infection Control Market

The increasing construction of hospitals due to rapid population growth and the rising prevalence of chronic health conditions propel the demand for infection control products and services. According to the Delhi Economic Survey, the construction of 11 structural medical facilities, including hospitals, is underway, while various established hospitals are being upgraded. One of the major concerns in hospitals is the risk of infection from drug-resistant bacteria and bloodborne pathogens, among others, in the operating theatre. For instance, the frequent utilization of catheters bolsters the risk of UTIs. Thus, hospitals should be urged to adopt effective infection control equipment and services as they aid in stopping the spread of infections. Infection control is paramount in hospitals, as it helps protect both healthcare workers and patients from diseases.

Future Market Scenario (2024-2031F)

According to the global infection control market analysis, infection control will become the cornerstone of healthcare in the coming years for preventing the transmission of infections across medical settings. The focus on infection control is expected to grow due to the increasing prevalence of hospital-acquired infections and the rising emphasis on patient safety across the globe. Technological advancements and integration of the internet of things and automated systems are further expected to propel the expansion of the infection control market by aiding in optimizing sterilization methods. Innovations in sterilization systems will also aid healthcare professionals in overcoming the various challenges posed by complex and novel medical devices that may require varying sterilization approaches.

Key Players Landscape and Outlook

The major players operating in the global infection control market are 3M, Getinge AB, Steric Plc, Sotera Health, Advanced Sterilization Products, Inc., and MATACHANA GROUP. The expansion of the market is supported by increasing mergers and acquisitions. In October 2023, Medicom Group, one of the leading providers of infection control and prevention solutions, announced the acquisition of Humask portfolio. The transaction also included the intellectual property and technologies developed by the company. This partnership is expected to ensure the availability and continuity of Humask's wide range of innovative protective equipment.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Infection Control Market Outlook, 2017-2031F

4.1.Market Size & Forecast
- 4.1.1.By Value
- 4.1.2.By Volume
4.2.By Type
- 4.2.1.Services
  - 4.2.1.1.Infectious Waste Disposal
  - 4.2.1.2.Contract Sterilization
    - 4.2.1.2.1.E-Beam Sterilization
    - 4.2.1.2.2.Gamma Sterilization
    - 4.2.1.2.3.Ethylene Oxide Sterilization
    - 4.2.1.2.4.Others
- 4.2.2.Equipment
  - 4.2.2.1.Sterilization Equipment
    - 4.2.2.1.1.Radiation Sterilization Equipment
    - 4.2.2.1.2.Filtration Sterilization Equipment
    - 4.2.2.1.3.Heat Sterilization Equipment
    - 4.2.2.1.4.Low Temperature Sterilization Equipment
    - 4.2.2.1.5.Liquid Sterilization Equipment
  - 4.2.2.2.Disinfectors
    - 4.2.2.2.1.Washers
    - 4.2.2.2.2.Endoscope Reprocessors
    - 4.2.2.2.3.Flushes
  - 4.2.2.3.Others
- 4.2.3.Consumables
  - 4.2.3.1.Sterilization Consumables
  - 4.2.3.2.Disinfectants
  - 4.2.3.3.Personal Protective Equipment
  - 4.2.3.4.Others
4.3.By Product
- 4.3.1.Sterilization Products
- 4.3.2.Cleaning and Disinfection Products
- 4.3.3.Personal Protective Barriers
- 4.3.4.Endoscope Reprocessing Products
- 4.3.5.Anti-Microbial Surfaces
- 4.3.6.Other Infection Control Products
4.4.By Application
- 4.4.1.Surgical Instruments
- 4.4.2.Endoscopes
- 4.4.3.Ultrasound Probes
- 4.4.4.Others
4.5.By End-user
- 4.5.1.Hospitals
- 4.5.2.Clinics
- 4.5.3.Diagnostic Laboratories
- 4.5.4.Medical Device Companies
- 4.5.5.Biotechnology and Pharmaceutical Companies
- 4.5.6.Others
4.6.By Distribution Channel
- 4.6.1.Retail Sales
- 4.6.2.Third Party Distributors
- 4.6.3.Direct Tender
4.7.By Region
- 4.7.1.North America
- 4.7.2.South America
- 4.7.3.Europe
- 4.7.4.Asia-Pacific
- 4.7.5.Middle East and Africa
4.8.By Company Market Share (%), 2023

5.Global Infection Control Market Outlook, By Region, 2017-2031F

5.1.North America*
- 5.1.1.Market Size & Forecast
  - 5.1.1.1.By Value
  - 5.1.1.2.By Volume
- 5.1.2.By Type
  - 5.1.2.1.Services
    - 5.1.2.1.1.Infectious Waste Disposal
    - 5.1.2.1.2.Contract Sterilization
      - 5.1.2.1.2.1.E-Beam Sterilization
      - 5.1.2.1.2.2.Gamma Sterilization
      - 5.1.2.1.2.3.Ethylene Oxide Sterilization
      - 5.1.2.1.2.4.Others
  - 5.1.2.2.Equipment
    - 5.1.2.2.1.Sterilization Equipment
      - 5.1.2.2.1.1.Radiation Sterilization Equipment
      - 5.1.2.2.1.2.Filtration Sterilization Equipment
      - 5.1.2.2.1.3.Heat Sterilization Equipment
      - 5.1.2.2.1.4.Low Temperature Sterilization Equipment
      - 5.1.2.2.1.5.Liquid Sterilization Equipment
    - 5.1.2.2.2.Disinfectors
      - 5.1.2.2.2.1.Washers
      - 5.1.2.2.2.2.Endoscope Reprocessors
      - 5.1.2.2.2.3.Flushes
    - 5.1.2.2.3.Others
  - 5.1.2.3.Consumables
    - 5.1.2.3.1.Sterilization Consumables
    - 5.1.2.3.2.Disinfectants
    - 5.1.2.3.3.Personal Protective Equipment
    - 5.1.2.3.4.Others
- 5.1.3.By Product
  - 5.1.3.1.Sterilization Products
  - 5.1.3.2.Cleaning and Disinfection Products
  - 5.1.3.3.Personal Protective Barriers
  - 5.1.3.4.Endoscope Reprocessing Products
  - 5.1.3.5.Anti-Microbial Surfaces
  - 5.1.3.6.Other Infection Control Products
- 5.1.4.By Application
  - 5.1.4.1.Surgical Instruments
  - 5.1.4.2.Endoscopes
  - 5.1.4.3.Ultrasound Probes
  - 5.1.4.4.Others
- 5.1.5.By End-user
  - 5.1.5.1.Hospitals
  - 5.1.5.2.Clinics
  - 5.1.5.3.Diagnostic Laboratories
  - 5.1.5.4.Medical Device Companies
  - 5.1.5.5.Biotechnology and Pharmaceutical Companies
  - 5.1.5.6.Others
- 5.1.6.By Distribution Channel
  - 5.1.6.1.Retail Sales
  - 5.1.6.2.Third Party Distributors
  - 5.1.6.3.Direct Tender
- 5.1.7.United States*
  - 5.1.7.1.Market Size & Forecast
    - 5.1.7.1.1.By Value
    - 5.1.7.1.2.By Volume
  - 5.1.7.2.By Type
    - 5.1.7.2.1.Services
      - 5.1.7.2.1.1.Infectious Waste Disposal
      - 5.1.7.2.1.2.Contract Sterilization
      - 5.1.7.2.1.2.1.E-Beam Sterilization
      - 5.1.7.2.1.2.2.Gamma Sterilization
      - 5.1.7.2.1.2.3.Ethylene Oxide Sterilization
      - 5.1.7.2.1.2.4.Others
    - 5.1.7.2.2.Equipment
      - 5.1.7.2.2.1.Sterilization Equipment
      - 5.1.7.2.2.1.1.Radiation Sterilization Equipment
      - 5.1.7.2.2.1.2.Filtration Sterilization Equipment
      - 5.1.7.2.2.1.3.Heat Sterilization Equipment
      - 5.1.7.2.2.1.4.Low Temperature Sterilization Equipment
      - 5.1.7.2.2.1.5.Liquid Sterilization Equipment
      - 5.1.7.2.2.2.Disinfectors
      - 5.1.7.2.2.2.1.Washers
      - 5.1.7.2.2.2.2.Endoscope Reprocessors
      - 5.1.7.2.2.2.3.Flushes
      - 5.1.7.2.2.3.Others
    - 5.1.7.2.3.Consumables
      - 5.1.7.2.3.1.Sterilization Consumables
      - 5.1.7.2.3.2.Disinfectants
      - 5.1.7.2.3.3.Personal Protective Equipment
      - 5.1.7.2.3.4.Others
  - 5.1.7.3.By Product
    - 5.1.7.3.1.Sterilization Products
    - 5.1.7.3.2.Cleaning and Disinfection Products
    - 5.1.7.3.3.Personal Protective Barriers
    - 5.1.7.3.4.Endoscope Reprocessing Products
    - 5.1.7.3.5.Anti-Microbial Surfaces
    - 5.1.7.3.6.Other Infection Control Products
  - 5.1.7.4.By Application
    - 5.1.7.4.1.Surgical Instruments
    - 5.1.7.4.2.Endoscopes
    - 5.1.7.4.3.Ultrasound Probes
    - 5.1.7.4.4.Others
  - 5.1.7.5.By End-user
    - 5.1.7.5.1.Hospitals
    - 5.1.7.5.2.Clinics
    - 5.1.7.5.3.Diagnostic Laboratories
    - 5.1.7.5.4.Medical Device Companies
    - 5.1.7.5.5.Biotechnology and Pharmaceutical Companies
    - 5.1.7.5.6.Others
  - 5.1.7.6.By Distribution Channel
    - 5.1.7.6.1.Retail Sales
    - 5.1.7.6.2.Third Party Distributors
    - 5.1.7.6.3.Direct Tender
- 5.1.8.Canada
- 5.1.9.Mexico

All segments will be provided for all regions and countries covered

5.2.Europe
- 5.2.1.Germany
- 5.2.2.France
- 5.2.3.Italy
- 5.2.4.United Kingdom
- 5.2.5.Russia
- 5.2.6.Netherlands
- 5.2.7.Spain
- 5.2.8.Turkey
- 5.2.9.Poland
5.3.Asia-Pacific
- 5.3.1.India
- 5.3.2.China
- 5.3.3.Japan
- 5.3.4.Australia
- 5.3.5.Vietnam
- 5.3.6.South Korea
- 5.3.7.Indonesia
- 5.3.8.Philippines
5.4.South America
- 5.4.1.Brazil
- 5.4.2.Argentina
5.5.Middle East and Africa
- 5.5.1.Saudi Arabia
- 5.5.2.UAE
- 5.5.3.South Africa

6.Market Mapping, 2023

6.1.By Type
6.2.By Product
6.3.By Application
6.4.By End-user
6.5.By Distribution Channel
6.6.By Region

7.Macro Environment and Industry Structure

7.1.Supply Demand Analysis
7.2.Import Export Analysis
7.3.Value Chain Analysis
7.4.PESTEL Analysis
- 7.4.1.Political Factors
- 7.4.2.Economic System
- 7.4.3.Social Implications
- 7.4.4.Technological Advancements
- 7.4.5.Environmental Impacts
- 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5.Porter's Five Forces Analysis
- 7.5.1.Supplier Power
- 7.5.2.Buyer Power
- 7.5.3.Substitution Threat
- 7.5.4.Threat From New Entrant
- 7.5.5.Competitive Rivalry

8.Market Dynamics

8.1.Growth Drivers
8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

9.1.Patent Landscape
9.2.Regulatory Approvals
9.3.Innovations/Emerging Technologies

10.Key Players Landscape

10.1.Competition Matrix of Top Five Market Leaders
10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4.SWOT Analysis (For Five Market Players)
10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

13.1.3M Company
- 13.1.1.Company Details
- 13.1.2.Key Management Personnel
- 13.1.3.Products and Services
- 13.1.4.Financials (As reported)
- 13.1.5.Key Market Focus and Geographical Presence
- 13.1.6.Recent Developments
13.2.Getinge AB
13.3.Steric Plc
13.4.Sotera Health
13.5.Advanced Sterilization Products, Inc.
13.6.MATACHANA GROUP
13.7.MMM Group
13.8.Belimed AG
13.9.Halyard Health (Owens & Minor, Inc.)
13.10.Ecolab Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

感染管理市場の評価：タイプ・製品・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Infection Control Market Assessment, By Type, By Product, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の感染管理市場の展望

第6章世界の感染管理市場の展望：地域別

第6章市場マッピング

第7章マクロ環境・産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Infection Control Market Outlook, 2017-2031F

5.Global Infection Control Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

感染管理市場の評価：タイプ・製品・用途・エンドユーザー・流通チャネル・地域別の機会および予測 (2017-2031年)

Infection Control Market Assessment, By Type, By Product, By Application, By End-user, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の感染管理市場の展望

第6章 世界の感染管理市場の展望：地域別

第6章 市場マッピング

第7章 マクロ環境・産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Infection Control Market Outlook, 2017-2031F

5.Global Infection Control Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の感染管理市場の展望

第6章世界の感染管理市場の展望：地域別

第6章市場マッピング

第7章マクロ環境・産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項